as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹8,889.0
Change
+0.5 (0.01%)
Open
₹8,891.0
Prev. Close
₹8,888.5
Day High
₹8,934.5
Day Low
₹8,821.5
Volume Analysis
Traded
438,457
Delivered
312,900
Delivery %
71.36%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong return on equity (21.2%)
Weaknesses (1)
- •Promoter holding is falling
Opportunities (1)
- •Strong 3-year EPS growth (33.3%)
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹9,054.84 | ₹8,994.67 | ₹8,941.84 | ₹8,881.67 | ₹8,828.84 | ₹8,768.67 | ₹8,715.84 |
| Fibonacci | ₹8,994.67 | ₹8,951.5 | ₹8,924.84 | ₹8,881.67 | ₹8,838.5 | ₹8,811.84 | ₹8,768.67 |
| Camarilla | ₹8,920.08 | ₹8,909.72 | ₹8,899.36 | ₹8,881.67 | ₹8,878.64 | ₹8,868.28 | ₹8,857.93 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+24.99%
1 Week
-0.26%
1 Month
+0.57%
3 Months
+2.38%
6 Months
+21.68%
1 Year
+18.36%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹1,415.03
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
21.93%
Net margin 8.22% × asset turnover 1.14x × equity multiplier 2.34x
Company Overview
Sector
Healthcare
Market Cap
₹128,055 Cr
P/E (TTM)
60.9
ROE
21.2%
Book Value
₹659.0
Face Value
₹5.0
Source: Screener.in (Consolidated figures) — data as of 25 Sep 2026. Not investment advice.
TopFund Analysis
Apollo Hospitals Enter. L holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 68/100. The strongest factor is Liquidity (100/100), while Valuation (1/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (21.2%); promoter holding is falling. FII holding has been falling.
TopFund Score — Fundamentals Quality
68/100 — GoodData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has delivered good profit growth of 76.2% CAGR over last 5 years
- +Company has been maintaining a healthy dividend payout of 17.7%
- −Stock is trading at 13.5 times its book value
- −Company might be capitalizing the interest cost
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Published newspaper ads for proposed transfer of shares to IEPF.
Apollo Hospitals held its 45th AGM on 25 Aug 2026; all eight resolutions passed, including dividend and appointments.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 4,418 | 4,847 | 4,851 | 4,944 | 5,086 | 5,589 | 5,527 | 5,592 | 5,842 | 6,304 | 6,477 | 6,606 | 7,044 |
| Expenses + | 3,909 | 4,219 | 4,237 | 4,303 | 4,410 | 4,774 | 4,765 | 4,822 | 4,990 | 5,362 | 5,512 | 5,594 | 5,951 |
| Operating Profit | 509 | 628 | 614 | 640 | 675 | 816 | 762 | 770 | 852 | 941 | 965 | 1,011 | 1,092 |
| OPM % | 12.0% | 13.0% | 13.0% | 13.0% | 13.0% | 15.0% | 14.0% | 14.0% | 15.0% | 15.0% | 15.0% | 15.0% | 16.0% |
| Other Income + | 34 | 26 | 29 | 37 | 49 | 44 | 69 | 72 | 54 | 61 | 48 | 54 | 62 |
| Interest | 106 | 111 | 113 | 119 | 116 | 118 | 110 | 115 | 108 | 110 | 113 | 119 | 120 |
| Depreciation | 167 | 163 | 167 | 190 | 177 | 184 | 185 | 211 | 215 | 218 | 219 | 224 | 235 |
| Profit before tax | 270 | 379 | 363 | 368 | 430 | 557 | 536 | 516 | 583 | 675 | 682 | 722 | 799 |
| Tax % | 36.0% | 34.0% | 30.0% | 30.0% | 27.0% | 29.0% | 29.0% | 20.0% | 24.0% | 27.0% | 24.0% | 24.0% | 24.0% |
| Net Profit + | 173 | 249 | 254 | 258 | 316 | 396 | 379 | 414 | 441 | 494 | 516 | 551 | 610 |
| EPS in Rs | 12 | 16 | 17 | 18 | 21 | 26 | 26 | 27 | 30 | 33 | 35 | 37 | 40 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 5,129 | 6,150 | 7,256 | 8,243 | 9,617 | 11,247 | 10,560 | 14,663 | 16,612 | 19,059 | 21,794 | 25,228 | 26,430 |
| Expenses + | 4,392 | 5,465 | 6,522 | 7,442 | 8,548 | 9,656 | 9,420 | 12,474 | 14,548 | 16,665 | 18,761 | 21,449 | 22,420 |
| Operating Profit | 737 | 684 | 734 | 801 | 1,070 | 1,591 | 1,140 | 2,189 | 2,065 | 2,394 | 3,033 | 3,779 | 4,010 |
| OPM % | 14.0% | 11.0% | 10.0% | 10.0% | 11.0% | 14.0% | 11.0% | 15.0% | 12.0% | 13.0% | 14.0% | 15.0% | 15.0% |
| Other Income + | 47 | 92 | 60 | 24 | 26 | 222 | 103 | 368 | 75 | 123 | 222 | 207 | 226 |
| Interest | 118 | 180 | 257 | 295 | 327 | 533 | 449 | 379 | 381 | 449 | 458 | 450 | 462 |
| Depreciation | 212 | 264 | 314 | 359 | 396 | 620 | 573 | 601 | 615 | 687 | 758 | 876 | 896 |
| Profit before tax | 455 | 332 | 222 | 171 | 373 | 660 | 221 | 1,578 | 1,144 | 1,380 | 2,039 | 2,661 | 2,877 |
| Tax % | 29.0% | 29.0% | 41.0% | 65.0% | 47.0% | 34.0% | 38.0% | 30.0% | 22.0% | 32.0% | 26.0% | 25.0% | — |
| Net Profit + | 335 | 235 | 131 | 60 | 200 | 432 | 137 | 1,108 | 844 | 935 | 1,505 | 2,003 | 2,172 |
| EPS in Rs | 24 | 17 | 16 | 8 | 17 | 33 | 10 | 73 | 57 | 63 | 101 | 135 | 145 |
| Dividend Payout % | 24.0% | 35.0% | 38.0% | 59.0% | 35.0% | 18.0% | 29.0% | 16.0% | 26.0% | 26.0% | 13.0% | 15.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 3,102 | 3,262 | 3,244 | 3,182 | 3,264 | 3,270 | 4,531 | 5,551 | 6,126 | 6,864 | 8,140 | 9,408 |
| Borrowings + | 1,992 | 2,834 | 3,125 | 3,427 | 3,673 | 3,596 | 4,160 | 4,068 | 4,332 | 5,333 | 7,864 | 8,493 |
| Other Liabilities + | 1,296 | 1,195 | 1,665 | 1,917 | 2,159 | 4,354 | 2,629 | 3,570 | 3,886 | 4,474 | 4,568 | 4,210 |
| Total Liabilities | 6,459 | 7,360 | 8,103 | 8,596 | 9,166 | 11,289 | 11,392 | 13,261 | 14,416 | 16,742 | 20,644 | 22,183 |
| Fixed Assets + | 3,244 | 3,997 | 4,591 | 4,773 | 4,982 | 7,432 | 6,778 | 8,296 | 8,520 | 9,664 | 10,988 | 12,272 |
| CWIP | 533 | 562 | 347 | 712 | 822 | 236 | 234 | 46 | 610 | 873 | 921 | 1,032 |
| Investments | 311 | 352 | 406 | 352 | 462 | 434 | 1,343 | 816 | 574 | 986 | 2,487 | 2,179 |
| Other Assets + | 2,372 | 2,448 | 2,759 | 2,759 | 2,901 | 3,187 | 3,037 | 4,104 | 4,712 | 5,219 | 6,248 | 6,700 |
| Total Assets | 6,459 | 7,360 | 8,103 | 8,596 | 9,166 | 11,289 | 11,392 | 13,261 | 14,416 | 16,742 | 20,644 | 22,183 |
| Equity Capital | 70 | 70 | 70 | 70 | 70 | 70 | 72 | 72 | 72 | 72 | 72 | 72 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 470 | 597 | 623 | 537 | 905 | 1,293 | 1,265 | 1,696 | 1,377 | 1,920 | 2,136 | 2,856 |
| Cash from Investing Activity + | -759 | -888 | -1,152 | -405 | -711 | -289 | -880 | -747 | -857 | -1,537 | -3,383 | -2,145 |
| Cash from Financing Activity + | 392 | 330 | 477 | -108 | -215 | -910 | -340 | -792 | -633 | -311 | 1,319 | -478 |
| Net Cash Flow | 103 | 39 | -52 | 24 | -20 | 94 | 44 | 158 | -113 | 72 | 73 | 233 |
| CFO/OP | 77 | 108 | 103 | 83 | 103 | 100 | 108 | 87 | 85 | 100 | 86 | 92 |
| Free Cash Flow | -396 | -393 | -46 | -84 | 233 | 782 | 984 | 1,044 | 252 | 785 | 439 | 925 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 5.68% | 5.32% | 5.26% | 5.38% | 5.12% | 5.21% | 5.41% | 5.61% | 6.43% | 6.71% | 6.39% | 6.53% |
| Promoters | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.34% | 29.34% | 28.02% | 28.02% | 28.02% | 28.02% |
| Government | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% |
| FII | 46.15% | 46.25% | 45.63% | 43.92% | 45.37% | 45.27% | 42.74% | 43.49% | 44.2% | 43.54% | 42.62% | 41.49% |
| DII | 18.59% | 18.87% | 19.55% | 21.13% | 19.94% | 19.97% | 22.29% | 21.34% | 21.12% | 21.5% | 22.76% | 23.72% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Apollo Hospitals Enter. L (this stock) | 128,055 | 60.9 | 13.51 | 21.2% |
| Zydus Lifesciences Ltd | 120,089 | 24.7 | 4.48 | 21.2% |
| Cipla Ltd | 111,060 | 31.0 | 3.23 | 11.6% |
| Laurus Labs Limited | 108,438 | 99.2 | 20.44 | 18.3% |
| Mankind Pharma Limited | 102,225 | 47.9 | 6.27 | 13.1% |
| Dr. Reddy S Laboratories | 101,096 | 31.4 | 2.67 | 11.2% |
| Aurobindo Pharma Ltd | 98,939 | 26.2 | 2.64 | 10.1% |
Which Mutual Funds Hold Apollo Hospitals Enter. L?
Frequently Asked Questions about Apollo Hospitals Enter. L
Apollo Hospitals Enter. L (APOLLOHOSP) closed at ₹8,889.0 on NSE on 25 September 2026, up 0.5 (0.01%) from the previous close.
Apollo Hospitals Enter. L trades on the NSE (National Stock Exchange of India) under the symbol APOLLOHOSP.
Apollo Hospitals Enter. L has a trailing twelve-month P/E (price-to-earnings) ratio of 60.9.
Apollo Hospitals Enter. L has a dividend yield of 0.23%.
Apollo Hospitals Enter. L's 52-week high is ₹9,327.0 and its 52-week low is ₹6,680.0.
Apollo Hospitals Enter. L has a market capitalisation of ₹128,055 crore.
Apollo Hospitals Enter. L has a TopFund Quality Score of 68/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Apollo Hospitals Enter. L?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.